Stock Events

Stock Events

Biomerieux 

$95.00
129
-$7.14-6.99%Friday 21:00

Statistics

Day High
95
Day Low
95
52W High
132.05
52W Low
77
Volume
105
Avg. Volume
64
Mkt Cap
11.24B
P/E Ratio
21.78
Dividend Yield
1.19%
Dividend
1.13

Upcoming

Dividends

1.19%Dividend Yield
Jun 2026
$1.13
Jun 2025
$1.04
Jun 2024
$0.91
Jun 2023
$0.92
Jun 2022
$0.91
10Y Growth
11.65%
5Y Growth
8.49%
3Y Growth
7.36%
1Y Growth
9.49%

Earnings

Jul 28Expected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
0
0.73
1.46
2.19
Expected EPS
2.03600289676
Actual EPS
1.99588461308

Financials

9.95%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
4.69BRevenue
467.26MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BMXMF. It's not an investment recommendation.
Sanofi
25
SAN.PA
Air Liquide
24
AI.PA
TotalEnergies
22
TTE.PA
Lvmh Moet Hennessy Louis Vuitton
19
MC.PA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap257.42B
Thermo Fisher Scientific offers a broad range of analytical instruments and reagents, directly competing in the diagnostics and research sectors similar to Biomerieux.
Danaher
DHR
Mkt Cap161.86B
Danaher Corporation, through its subsidiaries like Cepheid, competes in the life sciences and diagnostics market, offering products that overlap with Biomerieux's offerings.
Bio-Rad Laboratories
BIO
Mkt Cap10.26B
Bio-Rad Laboratories provides a variety of products for the life science research and clinical diagnostics markets, making it a direct competitor in several areas of Biomerieux's business.
Resmed
RMD
Mkt Cap33.1B
ResMed Inc. is known for its products in the health sector, including diagnostics, where it competes with Biomerieux in certain niches.
Becton Dickinson
BDX
Mkt Cap57.71B
Becton, Dickinson and Company operates in the healthcare and diagnostics industries, offering products and services that compete with Biomerieux's diagnostics solutions.
Qiagen NV
QGEN
Mkt Cap10.39B
Qiagen N.V. offers technologies and products for preanalytical sample preparation and diagnostics, competing in the molecular diagnostics market alongside Biomerieux.
Abbott Laboratories
ABT
Mkt Cap190.39B
Abbott Laboratories has a broad range of healthcare products including diagnostics, competing with Biomerieux especially in the areas of infectious disease testing.
Agilent Technologies
A
Mkt Cap49.27B
Agilent Technologies provides analytical instruments, services, and consumables in the life sciences, diagnostics, and applied chemical markets, competing with Biomerieux in laboratory diagnostics.
Guardant Health
GH
Mkt Cap20.41B
Guardant Health operates in the precision oncology field, offering liquid biopsy tests that compete with Biomerieux's molecular diagnostics solutions in the oncology segment.

About

bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
Show More
CEO
Pierre Boulud
Employees
14894
Country
France
ISIN
FR0013280286
WKN
000A2DXZH

Listings

OTC Link
US
BMXXY
STU
DE
EYWN.STU
MU
DE
EYWN.MU
PA
FR
BIM.PA

0 Comments

Share your thoughts

FAQs

What is Biomerieux stock price today?▼
The current price of BMXMF is $95.00 USD — it has decreased by -6.99% in the past 24 hours. Watch Biomerieux stock price performance more closely on the chart.
What is Biomerieux stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Biomerieux stocks are traded under the ticker BMXMF.
Is Biomerieux stock price growing?▼
BMXMF stock has fallen by -6.99% compared to the previous week, the month change is a +11.76% rise, over the last year Biomerieux has showed a -26.35% decrease.
What is Biomerieux market cap?▼
Today Biomerieux has the market capitalization of 11.24B
When is the next Biomerieux earnings date?▼
Biomerieux is going to release the next earnings report on February 26, 2027.
What were Biomerieux earnings last quarter?▼
BMXMF earnings for the last quarter are 2.27 USD per share, whereas the estimation was 2.32 USD resulting in a -1.97% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Biomerieux revenue for the last year?▼
Biomerieux revenue for the last year amounts to 4.69B USD.
What is Biomerieux net income for the last year?▼
BMXMF net income for the last year is 467.26M USD.
Does Biomerieux pay dividends?▼
Yes, BMXMF dividends are paid annual. The last dividend per share was 1.13 . As of today, Dividend Yield (FWD)% is 1.19%.
How many employees does Biomerieux have?▼
As of November 10, 2026, the company has 14,894 employees.
In which sector is Biomerieux located?▼
Biomerieux operates in the Health & Wellness sector.
When did Biomerieux complete a stock split?▼
The last stock split for Biomerieux was on September 21, 2017 with a ratio of 3:1.
Where is Biomerieux headquartered?▼
Biomerieux is headquartered in Marcy l'Étoile, France.